<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD06390000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P01116</UniProt_ID>
  <Seq_Length>189</Seq_Length>
  <Molecule_Weight>21656</Molecule_Weight>
  <KEGG_ID>hsa:3845</KEGG_ID>
  <Orthology_ID>K07827</Orthology_ID>
  <EBI_ID>EBI-367415</EBI_ID>
  <Function_Summary>Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.</Function_Summary>
  <Pfam_ID>PF00071:Ras</Pfam_ID>
  <Allosteric_Activator_Count>6</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>25</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>c-Ki-ras</Alias>
      <Alias>Ki-Ras</Alias>
      <Alias>K-Ras 2</Alias>
      <Alias>c-K-ras</Alias>
      <Alias>GTPase KRas, N-terminally processed</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with GTP, guanosine triphosphate.</Detail>
      <Keyword>GTP binding</Keyword>
      <Ontology_ID>GO:0005525</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>60</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>14</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>61</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>22</Position>
      <Original>Gln</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>58</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>13</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>36</Position>
      <Original>Ile</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>5</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>13</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>34</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>61</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>5</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>34</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>59</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>60</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>22</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>34</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>117</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.</Detail>
      <Keyword>Insulin receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0008286</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the nerve growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Nerve growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048011</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Fibroblast growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0008543</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The movement of a leukocyte within or between different tissues and organs of the body.</Detail>
      <Keyword>Leukocyte migration</Keyword>
      <Ontology_ID>GO:0050900</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of an epidermal growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Epidermal growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0007173</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.</Detail>
      <Keyword>Ras protein signal transduction</Keyword>
      <Ontology_ID>GO:0007265</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme MAP kinase kinase by phosphorylation by a MAPKKK.</Detail>
      <Keyword>Activation of MAPKK activity</Keyword>
      <Ontology_ID>GO:0000186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.</Detail>
      <Keyword>Positive regulation of gene expression</Keyword>
      <Ontology_ID>GO:0010628</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.</Detail>
      <Keyword>Axon guidance</Keyword>
      <Ontology_ID>GO:0007411</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.</Detail>
      <Keyword>Positive regulation of protein phosphorylation</Keyword>
      <Ontology_ID>GO:0001934</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cascade of at least three protein kinase activities culminating in the phosphorylation and activation of a MAP kinase. MAPKKK cascades lie downstream of numerous signaling pathways.</Detail>
      <Keyword>MAPKKK cascade</Keyword>
      <Ontology_ID>GO:0000165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>186</Position>
      <PTM_Type>Cysteine methyl ester</PTM_Type>
    </PTM>
    <PTM>
      <Position>1</Position>
      <PTM_Type>N-acetylmethionine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylthreonine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM</Protein_Seq>
    <DNA_Seq>GGCCGCGGCGGCGGAGGCAGCAGCGGCGGCGGCAGTGGCGGCGGCGAAGGTGGCGGCGGCTCGGCCAGTACTCCCGGCCCCCGCCATTTCGGACTGGGAGCGAGCGCGGCGCAGGCACTGAAGGCGGCGGCGGGGCCAGAGGCTCAGCGGCTCCCAGGTGCGGGAGAGAGGCCTGCTGAAAATGACTGAATATAAACTTGTGGTAGTTGGAGCTGGTGGCGTAGGCAAGAGTGCCTTGACGATACAGCTAATTCAGAATCATTTTGTGGACGAATATGATCCAACAATAGAGGATTCCTACAGGAAGCAAGTAGTAATTGATGGAGAAACCTGTCTCTTGGATATTCTCGACACAGCAGGTCAAGAGGAGTACAGTGCAATGAGGGACCAGTACATGAGGACTGGGGAGGGCTTTCTTTGTGTATTTGCCATAAATAATACTAAATCATTTGAAGATATTCACCATTATAGAGAACAAATTAAAAGAGTTAAGGACTCTGAAGATGTACCTATGGTCCTAGTAGGAAATAAATGTGATTTGCCTTCTAGAACAGTAGACACAAAACAGGCTCAGGACTTAGCAAGAAGTTATGGAATTCCTTTTATTGAAACATCAGCAAAGACAAGACAGGGTGTTGATGATGCCTTCTATACATTAGTTCGAGAAATTCGAAAACATAAAGAAAAGATGAGCAAAGATGGTAAAAAGAAGAAAAAGAAGTCAAAGACAAAGTGTGTAATTATGTAAATACAATTTGTACTTTTTTCTTAAGGCATACTAGTACAAGTGGTAATTTTTGTACATTACACTAAATTATTAGCATTTGTTTTAGCATTACCTAATTTTTTTCCTGCTCCATGCAGACTGTTAGCTTTTACCTTAAATGCTTATTTTAAAATGACAGTGGAAGTTTTTTTTTCCTCTAAGTGCCAGTATTCCCAGAGTTTTGGTTTTTGAACTAGCAATGCCTGTGAAAAAGAAACTGAATACCTAAGATTTCTGTCTTGGGGTTTTTGGTGCATGCAGTTGATTACTTCTTATTTTTCTTACCAATTGTGAATGTTGGTGTGAAACAAATTAATGAAGCTTTTGAATCATCCCTATTCTGTGTTTTATCTAGTCACATAAATGGATTAATTACTAATTTCAGTTGAGACCTTCTAATTGGTTTTTACTGAAACATTGAGGGAACACAAATTTATGGGCTTCCTGATGATGATTCTTCTAGGCATCATGTCCTATAGTTTGTCATCCCTGATGAATGTAAAGTTACACTGTTCACAAAGGTTTTGTCTCCTTTCCACTGCTATTAGTCATGGTCACTCTCCCCAAAATATTATATTTTTTCTATAAAAAGAAAAAAATGGAAAAAAATTACAAGGCAATGGAAACTATTATAAGGCCATTTCCTTTTCACATTAGATAAATTACTATAAAGACTCCTAATAGCTTTTCCTGTTAAGGCAGACCCAGTATGAAATGGGGATTATTATAGCAACCATTTTGGGGCTATATTTACATGCTACTAAATTTTTATAATAATTGAAAAGATTTTAACAAGTATAAAAAATTCTCATAGGAATTAAATGTAGTCTCCCTGTGTCAGACTGCTCTTTCATAGTATAACTTTAAATCTTTTCTTCAACTTGAGTCTTTGAAGATAGTTTTAATTCTGCTTGTGACATTAAAAGATTATTTGGGCCAGTTATAGCTTATTAGGTGTTGAAGAGACCAAGGTTGCAAGGCCAGGCCCTGTGTGAACCTTTGAGCTTTCATAGAGAGTTTCACAGCATGGACTGTGTCCCCACGGTCATCCAGTGTTGTCATGCATTGGTTAGTCAAAATGGGGAGGGACTAGGGCAGTTTGGATAGCTCAACAAGATACAATCTCACTCTGTGGTGGTCCTGCTGACAAATCAAGAGCATTGCTTTTGTTTCTTAAGAAAACAAACTCTTTTTTAAAAATTACTTTTAAATATTAACTCAAAAGTTGAGATTTTGGGGTGGTGGTGTGCCAAGACATTAATTTTTTTTTTAAACAATGAAGTGAAAAAGTTTTACAATCTCTAGGTTTGGCTAGTTCTCTTAACACTGGTTAAATTAACATTGCATAAACACTTTTCAAGTCTGATCCATATTTAATAATGCTTTAAAATAAAAATAAAAACAATCCTTTTGATAAATTTAAAATGTTACTTATTTTAAAATAAATGAAGTGAGATGGCATGGTGAGGTGAAAGTATCACTGGACTAGGAAGAAGGTGACTTAGGTTCTAGATAGGTGTCTTTTAGGACTCTGATTTTGAGGACATCACTTACTATCCATTTCTTCATGTTAAAAGAAGTCATCTCAAACTCTTAGTTTTTTTTTTTTACAACTATGTAATTTATATTCCATTTACATAAGGATACACTTATTTGTCAAGCTCAGCACAATCTGTAAATTTTTAACCTATGTTACACCATCTTCAGTGCCAGTCTTGGGCAAAATTGTGCAAGAGGTGAAGTTTATATTTGAATATCCATTCTCGTTTTAGGACTCTTCTTCCATATTAGTGTCATCTTGCCTCCCTACCTTCCACATGCCCCATGACTTGATGCAGTTTTAATACTTGTAATTCCCCTAACCATAAGATTTACTGCTGCTGTGGATATCTCCATGAAGTTTTCCCACTGAGTCACATCAGAAATGCCCTACATCTTATTTCCTCAGGGCTCAAGAGAATCTGACAGATACCATAAAGGGATTTGACCTAATCACTAATTTTCAGGTGGTGGCTGATGCTTTGAACATCTCTTTGCTGCCCAATCCATTAGCGACAGTAGGATTTTTCAAACCTGGTATGAATAGACAGAACCCTATCCAGTGGAAGGAGAATTTAATAAAGATAGTGCTGAAAGAATTCCTTAGGTAATCTATAACTAGGACTACTCCTGGTAACAGTAATACATTCCATTGTTTTAGTAACCAGAAATCTTCATGCAATGAAAAATACTTTAATTCATGAAGCTTACTTTTTTTTTTTGGTGTCAGAGTCTCGCTCTTGTCACCCAGGCTGGAATGCAGTGGCGCCATCTCAGCTCACTGCAACCTCCATCTCCCAGGTTCAAGCGATTCTCGTGCCTCGGCCTCCTGAGTAGCTGGGATTACAGGCGTGTGCCACTACACTCAACTAATTTTTGTATTTTTAGGAGAGACGGGGTTTCACCCTGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCAAGTGATTCACCCACCTTGGCCTCATAAACCTGTTTTGCAGAACTCATTTATTCAGCAAATATTTATTGAGTGCCTACCAGATGCCAGTCACCGCACAAGGCACTGGGTATATGGTATCCCCAAACAAGAGACATAATCCCGGTCCTTAGGTAGTGCTAGTGTGGTCTGTAATATCTTACTAAGGCCTTTGGTATACGACCCAGAGATAACACGATGCGTATTTTAGTTTTGCAAAGAAGGGGTTTGGTCTCTGTGCCAGCTCTATAATTGTTTTGCTACGATTCCACTGAAACTCTTCGATCAAGCTACTTTATGTAAATCACTTCATTGTTTTAAAGGAATAAACTTGATTATATTGTTTTTTTATTTGGCATAACTGTGATTCTTTTAGGACAATTACTGTACACATTAAGGTGTATGTCAGATATTCATATTGACCCAAATGTGTAATATTCCAGTTTTCTCTGCATAAGTAATTAAAATATACTTAAAAATTAATAGTTTTATCTGGGTACAAATAAACAGGTGCCTGAACTAGTTCACAGACAAGGAAACTTCTATGTAAAAATCACTATGATTTCTGAATTGCTATGTGAAACTACAGATCTTTGGAACACTGTTTAGGTAGGGTGTTAAGACTTACACAGTACCTCGTTTCTACACAGAGAAAGAAATGGCCATACTTCAGGAACTGCAGTGCTTATGAGGGGATATTTAGGCCTCTTGAATTTTTGATGTAGATGGGCATTTTTTTAAGGTAGTGGTTAATTACCTTTATGTGAACTTTGAATGGTTTAACAAAAGATTTGTTTTTGTAGAGATTTTAAAGGGGGAGAATTCTAGAAATAAATGTTACCTAATTATTACAGCCTTAAAGACAAAAATCCTTGTTGAAGTTTTTTTAAAAAAAGCTAAATTACATAGACTTAGGCATTAACATGTTTGTGGAAGAATATAGCAGACGTATATTGTATCATTTGAGTGAATGTTCCCAAGTAGGCATTCTAGGCTCTATTTAACTGAGTCACACTGCATAGGAATTTAGAACCTAACTTTTATAGGTTATCAAAACTGTTGTCACCATTGCACAATTTTGTCCTAATATATACATAGAAACTTTGTGGGGCATGTTAAGTTACAGTTTGCACAAGTTCATCTCATTTGTATTCCATTGATTTTTTTTTTCTTCTAAACATTTTTTCTTCAAACAGTATATAACTTTTTTTAGGGGATTTTTTTTTAGACAGCAAAAACTATCTGAAGATTTCCATTTGTCAAAAAGTAATGATTTCTTGATAATTGTGTAGTAATGTTTTTTAGAACCCAGCAGTTACCTTAAAGCTGAATTTATATTTAGTAACTTCTGTGTTAATACTGGATAGCATGAATTCTGCATTGAGAAACTGAATAGCTGTCATAAAATGAAACTTTCTTTCTAAAGAAAGATACTCACATGAGTTCTTGAAGAATAGTCATAACTAGATTAAGATCTGTGTTTTAGTTTAATAGTTTGAAGTGCCTGTTTGGGATAATGATAGGTAATTTAGATGAATTTAGGGGAAAAAAAAGTTATCTGCAGATATGTTGAGGGCCCATCTCTCCCCCCACACCCCCACAGAGCTAACTGGGTTACAGTGTTTTATCCGAAAGTTTCCAATTCCACTGTCTTGTGTTTTCATGTTGAAAATACTTTTGCATTTTTCCTTTGAGTGCCAATTTCTTACTAGTACTATTTCTTAATGTAACATGTTTACCTGGAATGTATTTTAACTATTTTTGTATAGTGTAAACTGAAACATGCACATTTTGTACATTGTGCTTTCTTTTGTGGGACATATGCAGTGTGATCCAGTTGTTTTCCATCATTTGGTTGCGCTGACCTAGGAATGTTGGTCATATCAAACATTAAAAATGACCACTCTTTTAATTGAAATTAACTTTTAAATGTTTATAGGAGTATGTGCTGTGAAGTGATCTAAAATTTGTAATATTTTTGTCATGAACTGTACTACTCCTAATTATTGTAATGTAATAAAAATAGTTACAGTGACAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>KRAS</Gene_Name>
    <Gene_Alias>KRAS2; RASK2</Gene_Alias>
    <Gene_ID>3845</Gene_ID>
    <Genbank_ACCN>NM_004985</Genbank_ACCN>
    <Protein_ACCN>NP_004976</Protein_ACCN>
    <HGNC_ID>6407</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/3845</Gene_URL>
    <UCSC_ID>uc001rgq.1</UCSC_ID>
    <EMBL_ID>ENSG00000133703</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P04049</Uniprot_ID>
      <Gene_Name>RAF1</Gene_Name>
      <EBI_ID>EBI-365996</EBI_ID>
      <PPI_EBI_URL>EBI-367415,EBI-365996</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q04631</Uniprot_ID>
      <Gene_Name>Fnta</Gene_Name>
      <EBI_ID>EBI-602447</EBI_ID>
      <PPI_EBI_URL>EBI-367415,EBI-602447</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P50749</Uniprot_ID>
      <Gene_Name>RASSF2</Gene_Name>
      <EBI_ID>EBI-960081</EBI_ID>
      <PPI_EBI_URL>EBI-367415,EBI-960081</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Adenocarcinoma, Ovarian, Somatic</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma_ovarian_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Selection of Therapeutic Option in Non-Small Cell Lung Carcinoma</Disease_Name>
      <Disease_Detail>Non-Small Cell Lung Carcinoma</Disease_Detail>
      <Disease_DB>SLC025</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/selection_of_therapeutic_option_in_non_small_cell_lung_carcinoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Cancer, Somatic</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR078</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_cancer_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Noonan Syndrome 3</Disease_Name>
      <Disease_Detail>Noonan Syndrome</Disease_Detail>
      <Disease_DB>NNN010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/noonan_syndrome_3?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cronkhite-Canada Syndrome</Disease_Name>
      <Disease_Detail>Cronkhite-Canada Syndrome</Disease_Detail>
      <Disease_DB>CRN014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cronkhite_canada_syndrome?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hyperplastic Polyposis Syndrome</Disease_Name>
      <Disease_Detail>Hyperplastic Polyposis Syndrome</Disease_Detail>
      <Disease_DB>HYP466</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hyperplastic_polyposis_syndrome?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Blastoma</Disease_Name>
      <Disease_Detail>Blastoma</Disease_Detail>
      <Disease_DB>BLS003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/blastoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma of Lung, Somatic</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma_of_lung_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nevus Sebaceous, Somatic</Disease_Name>
      <Disease_Detail>Nevus Sebaceous, Somatic</Disease_Detail>
      <Disease_DB>NVS013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nevus_sebaceous_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colon Adenoma</Disease_Name>
      <Disease_Detail>Colon Cancer</Disease_Detail>
      <Disease_DB>CLN044</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colon_adenoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN036</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma_of_lung_response_to_tyrosine_kinase_inhibitor_in?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiofaciocutaneous Syndrome</Disease_Name>
      <Disease_Detail>Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>CRD013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiofaciocutaneous_syndrome?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Liver Angiosarcoma</Disease_Name>
      <Disease_Detail>Liver Cancer</Disease_Detail>
      <Disease_DB>LVR002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/liver_angiosarcoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Schimmelpenning-Feuerstein-Mims Syndrome, Somatic Mosaic</Disease_Name>
      <Disease_Detail>Schimmelpenning-Feuerstein-Mims Syndrome, Somatic Mosaic</Disease_Detail>
      <Disease_DB>SCH063</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/schimmelpenning_feuerstein_mims_syndrome_somatic_mosaic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colon Cancer</Disease_Name>
      <Disease_Detail>Colon Cancer</Disease_Detail>
      <Disease_DB>CLN016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colon_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Adenocarcinoma</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_adenocarcinoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myeloid Leukemia, Acute, M4/m4eo Subtype, Somatic</Disease_Name>
      <Disease_Detail>Acute Myeloid Leukemia</Disease_Detail>
      <Disease_DB>MYL050</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myeloid_leukemia_acute_m4_m4eo_subtype_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Noonan Syndrome 1</Disease_Name>
      <Disease_Detail>Noonan Syndrome</Disease_Detail>
      <Disease_DB>NNN008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/noonan_syndrome_1?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leukemia, Acute Myeloid, Somatic</Disease_Name>
      <Disease_Detail>Acute Myeloid Leukemia</Disease_Detail>
      <Disease_DB>LKM016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leukemia_acute_myeloid_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Villous Adenoma</Disease_Name>
      <Disease_Detail>Villous Adenoma</Disease_Detail>
      <Disease_DB>VLL006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/villous_adenoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatic Cancer</Disease_Name>
      <Disease_Detail>Pancreatic Cancer</Disease_Detail>
      <Disease_DB>PNC035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatic_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Kras-Related Cardiofaciocutaneous Syndrome</Disease_Name>
      <Disease_Detail>Kras-Related Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>KRS003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/kras_related_cardiofaciocutaneous_syndrome?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer, Somatic</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG061</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pilocytic Astrocytoma</Disease_Name>
      <Disease_Detail>Pilocytic Astrocytoma</Disease_Detail>
      <Disease_DB>PLC011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pilocytic_astrocytoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatic Carcinoma, Somatic</Disease_Name>
      <Disease_Detail>Pancreatic Cancer</Disease_Detail>
      <Disease_DB>PNC073</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatic_carcinoma_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Noonan Syndrome</Disease_Name>
      <Disease_Detail>Noonan Syndrome</Disease_Detail>
      <Disease_DB>NNN003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/noonan_syndrome?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endometrial Cancer, Familial</Disease_Name>
      <Disease_Detail>Endometrial Cancer</Disease_Detail>
      <Disease_DB>END056</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endometrial_cancer_familial?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intestinal Neoplasm</Disease_Name>
      <Disease_Detail>Intestinal Neoplasm</Disease_Detail>
      <Disease_DB>INT069</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intestinal_neoplasm?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mutyh-Associated Polyposis</Disease_Name>
      <Disease_Detail>Mutyh-Associated Polyposis</Disease_Detail>
      <Disease_DB>MTY001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mutyh_associated_polyposis?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endometrial Carcinoma, Somatic</Disease_Name>
      <Disease_Detail>Endometrial Cancer</Disease_Detail>
      <Disease_DB>END058</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endometrial_carcinoma_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenoma</Disease_Name>
      <Disease_Detail>Adenoma</Disease_Detail>
      <Disease_DB>ADN018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dengue Disease</Disease_Name>
      <Disease_Detail>Dengue Disease</Disease_Detail>
      <Disease_DB>DNG003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dengue_disease?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bladder Adenocarcinoma</Disease_Name>
      <Disease_Detail>Bladder Cancer</Disease_Detail>
      <Disease_DB>BLD039</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bladder_adenocarcinoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Selection of Therapeutic Option in Colorectal Cancer</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>SLC026</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/selection_of_therapeutic_option_in_colorectal_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Cancer</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Diffuse Gastric Cancer</Disease_Name>
      <Disease_Detail>Hereditary Diffuse Gastric Cancer</Disease_Detail>
      <Disease_DB>HRD027</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_diffuse_gastric_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Kras-Related Noonan Syndrome</Disease_Name>
      <Disease_Detail>Kras-Related Noonan Syndrome</Disease_Detail>
      <Disease_DB>KRS004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/kras_related_noonan_syndrome?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nonsmall Cell Lung Cancer, Response to Tyrosine Kinase Inhibitor in</Disease_Name>
      <Disease_Detail>Nonsmall Cell Lung Cancer</Disease_Detail>
      <Disease_DB>NNS021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nonsmall_cell_lung_cancer_response_to_tyrosine_kinase_inhibitor_in?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Neurofibromatosis</Disease_Name>
      <Disease_Detail>Neurofibromatosis</Disease_Detail>
      <Disease_DB>NRF002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/neurofibromatosis?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiofaciocutaneous Syndrome 2</Disease_Name>
      <Disease_Detail>Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>CRD163</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiofaciocutaneous_syndrome_2?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Juvenile Myelomonocytic Leukemia</Disease_Name>
      <Disease_Detail>Juvenile Myelomonocytic Leukemia</Disease_Detail>
      <Disease_DB>JVN004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/juvenile_myelomonocytic_leukemia?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastric Cancer</Disease_Name>
      <Disease_Detail>Gastric Cancer</Disease_Detail>
      <Disease_DB>GST053</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastric_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sfm Syndrome, Somatic Mosaic</Disease_Name>
      <Disease_Detail>Sfm Syndrome, Somatic Mosaic</Disease_Detail>
      <Disease_DB>SFM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sfm_syndrome_somatic_mosaic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Cancer</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Exanthem</Disease_Name>
      <Disease_Detail>Exanthem</Disease_Detail>
      <Disease_DB>EXN002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/exanthem?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiofaciocutaneous Syndrome 4</Disease_Name>
      <Disease_Detail>Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>CRD167</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiofaciocutaneous_syndrome_4?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma in Situ</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma_in_situ?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epidermal Nevus, Somatic</Disease_Name>
      <Disease_Detail>Epidermal Nevus</Disease_Detail>
      <Disease_DB>EPD053</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epidermal_nevus_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pseudomyxoma Peritonei</Disease_Name>
      <Disease_Detail>Pseudomyxoma Peritonei</Disease_Detail>
      <Disease_DB>PSD007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pseudomyxoma_peritonei?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bladder Cancer, Somatic</Disease_Name>
      <Disease_Detail>Bladder Cancer</Disease_Detail>
      <Disease_DB>BLD087</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bladder_cancer_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pulmonary Blastoma</Disease_Name>
      <Disease_Detail>Pulmonary Blastoma</Disease_Detail>
      <Disease_DB>PLM032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pulmonary_blastoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiofaciocutaneous Syndrome 3</Disease_Name>
      <Disease_Detail>Cardiofaciocutaneous Syndrome</Disease_Detail>
      <Disease_DB>CRD164</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiofaciocutaneous_syndrome_3?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Diffuse Gastric Cancer</Disease_Name>
      <Disease_Detail>Diffuse Gastric Cancer</Disease_Detail>
      <Disease_DB>DFF019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/diffuse_gastric_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ras-Associated Autoimmune Leukoproliferative Disease</Disease_Name>
      <Disease_Detail>Ras-Associated Autoimmune Leukoproliferative Disease</Disease_Detail>
      <Disease_DB>RSS008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ras_associated_autoimmune_leukoproliferative_disease?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer, Protection Against</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG068</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer_protection_against?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congenital Pulmonary Airway Malformation</Disease_Name>
      <Disease_Detail>Congenital Pulmonary Airway Malformation</Disease_Detail>
      <Disease_DB>CNG390</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congenital_pulmonary_airway_malformation?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Myeloid Leukemia</Disease_Name>
      <Disease_Detail>Acute Myeloid Leukemia</Disease_Detail>
      <Disease_DB>ACT019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_myeloid_leukemia?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bladder Cancer Susceptibility</Disease_Name>
      <Disease_Detail>Bladder Cancer</Disease_Detail>
      <Disease_DB>BLD101</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bladder_cancer_susceptibility?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leukemia, Acute Myeloid, Reduced Survival in</Disease_Name>
      <Disease_Detail>Acute Myeloid Leukemia</Disease_Detail>
      <Disease_DB>LKM017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leukemia_acute_myeloid_reduced_survival_in?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Non-Small Cell Lung Carcinoma</Disease_Name>
      <Disease_Detail>Non-Small Cell Lung Carcinoma</Disease_Detail>
      <Disease_DB>NNS005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/non_small_cell_lung_carcinoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bone Marrow Cancer</Disease_Name>
      <Disease_Detail>Bone Marrow Cancer</Disease_Detail>
      <Disease_DB>BNM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bone_marrow_cancer?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Cancer, Somatic</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS069</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_cancer_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastric Cancer, Somatic</Disease_Name>
      <Disease_Detail>Gastric Cancer</Disease_Detail>
      <Disease_DB>GST060</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastric_cancer_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endometrial Carcinoma</Disease_Name>
      <Disease_Detail>Endometrial Cancer</Disease_Detail>
      <Disease_DB>END042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endometrial_carcinoma?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nonsmall Cell Lung Cancer, Somatic</Disease_Name>
      <Disease_Detail>Nonsmall Cell Lung Cancer</Disease_Detail>
      <Disease_DB>NNS020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nonsmall_cell_lung_cancer_somatic?search=KRAS#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Myeloid Leukemia, Adult</Disease_Name>
      <Disease_Detail>Acute Myeloid Leukemia, Adult</Disease_Detail>
      <Disease_DB>ACT115</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_myeloid_leukemia_adult?search=KRAS#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule vinylsulfonamide 8 covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4LYF</PDB_ID>
      <Resolution>1.57</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4LYF</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390030</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule vinylsulfonamide 7 covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4M1O</PDB_ID>
      <Resolution>1.57</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4M1O</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390015</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A FARNESYLATED K-RAS4B PEPTIDE PRODUCT</PDB_Title>
      <PDB_ID>1KZP</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KZP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Reaction path of protein farnesyltransferase at atomic resolution</PubMed_Title>
      <Author>Long, S.B., et al.</Author>
      <Journal>Nature(2002)419:645-650</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12374986?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule vinylsulfonamide 14 covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4M1T</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4M1T</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390021</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4LYH</PDB_ID>
      <Resolution>1.37</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4LYH</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390032</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule disulfide 6 bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4LUC</PDB_ID>
      <Resolution>1.29</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4LUC</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390028</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule disulfide 4 covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4LV6</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4LV6</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390029</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CO-CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A K-RAS4B PEPTIDE SUBSTRATE AND FPP ANALOG AT 2.0A RESOLUTION</PDB_Title>
      <PDB_ID>1D8D</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D8D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures.</PubMed_Title>
      <Author>Long, S.B., et al.</Author>
      <Journal>Structure Fold.Des.(2000)8:209-222</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10673434?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule acrylamide 16 covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4M22</PDB_ID>
      <Resolution>2.09</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4M22</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390014</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule vinylsulfonamide 15 covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4M1Y</PDB_ID>
      <Resolution>1.49</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4M1Y</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390025</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule acrylamide 11 covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4M21</PDB_ID>
      <Resolution>1.94</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4M21</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390026</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12C, alternative space group</PDB_Title>
      <PDB_ID>4LYJ</PDB_ID>
      <Resolution>1.93</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4LYJ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390032</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule vinylsulfonamide covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4M1W</PDB_ID>
      <Resolution>1.58</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4M1W</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390024</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FARNESYLATED K-RAS4B PEPTIDE PRODUCT AND FARNESYL DIPHOSPHATE SUBSTRATE BOUND SIMULTANEOUSLY</PDB_Title>
      <PDB_ID>1KZO</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KZO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Reaction Path of Protein Farnesyltransferase at Atomic Resolution</PubMed_Title>
      <Author>Long, S.B., et al.</Author>
      <Journal>Nature(2002)419:645-650</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12374986?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human K-Ras in complex with a GTP analogue</PDB_Title>
      <PDB_ID>3GFT</PDB_ID>
      <Resolution>2.27</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GFT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Human K-Ras in complex with a GTP analogue</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Zinc-depleted FTase complexed with K-RAS4B peptide substrate and FPP analog.</PDB_Title>
      <PDB_ID>1D8E</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D8E</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures.</PubMed_Title>
      <Author>Long, S.B., et al.</Author>
      <Journal>Structure Fold.Des.(2000)8:209-222</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10673434?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of small molecule vinylsulfonamide 13 covalently bound to K-Ras G12C</PDB_Title>
      <PDB_ID>4M1S</PDB_ID>
      <Resolution>1.55</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4M1S</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06390020</ASD_Ligand>
      <PubMed_Title>K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.</PubMed_Title>
      <Author>Ostrem, J.M., et al.</Author>
      <Journal>Nature(2013)503:548-551</Journal>
      <PubMed_ID>24256730</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04013</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway - fly</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04013</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway - fly</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04320</Pathway_ID>
      <Pathway_Title>Dorso-ventral axis formation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Development</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04013</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway - fly</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05212</Pathway_ID>
      <Pathway_Title>Pancreatic cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05221</Pathway_ID>
      <Pathway_Title>Acute myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04914</Pathway_ID>
      <Pathway_Title>Progesterone-mediated oocyte maturation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05223</Pathway_ID>
      <Pathway_Title>Non-small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05213</Pathway_ID>
      <Pathway_Title>Endometrial cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05210</Pathway_ID>
      <Pathway_Title>Colorectal cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04960</Pathway_ID>
      <Pathway_Title>Aldosterone-regulated sodium reabsorption</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Excretory system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All alpha proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.b.cac.f.d.b.html</SCOP_URL>
    <CATH_Class>Class 1: Mainly Alpha</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1d8d</CATH_URL>
  </Fold>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD06390001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390004</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390005</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390006</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390012</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390013</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06390032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09270001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>